Shanghai Institute of Hematology at Ruijin Hospital, SJTU
上海交通大学医学院附属瑞金医院血液学研究所

China

1 June 2020 - 31 May 2021

Parent institution: Ruijin Hospital, SJTU

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Shanghai Institute of Hematology at Ruijin Hospital, SJTU published between 1 June 2020 - 31 May 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
5 1.97

Outputs by subject (Share)

Subject Count Share
Life Sciences 5 1.97
1 0.45
1 0.50
PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS driven cancer cells
2020-10-29
0.50
3 1.02

Top articles by Altmetric score in current window

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Proceedings of the National Academy of Sciences of the United States of America

2021-02-09

RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation

Proceedings of the National Academy of Sciences of the United States of America

2020-06-08

Return to institution outputs